GSK329

Overview

GSK329 is a potent and selective diarylurea inhibitor of the cardiac-specific kinase TNNI3K . GSK329 exhibits positive cardioprotective outcomes in the model of ischemia/reperfusion cardiac injury.

Application

Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Lipid Metabolism | Products > Disease Areas > Cardiovascular Disease | Products > Disease Areas > Obesity | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > MAP3K

Product Information

• Catalog No.: HY-117243
• CAS No.: 1268490-12-5
• Molecular Formula: C19H14Cl2F3N5O2
• Molecular Weight: 472.25
• Purity: 99.60%
• Storage: 4°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Solubility: ≥ 2.08 mg/mL (4.40 mM); Clear solution
• Availability: In-stock

Source

Original product source